EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update

CPG Panel, A Berzigotti, E Tsochatzis, J Boursier… - Journal of …, 2021 - Elsevier
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …

Imaging features of primary sclerosing cholangitis: from diagnosis to liver transplant follow-up

P Khoshpouri, RR Habibabadi, B Hazhirkarzar… - Radiographics, 2019 - pubs.rsna.org
Primary sclerosing cholangitis (PSC) is a chronic progressive inflammatory disease of the
bile ducts that leads to multifocal bile duct fibrosis, strictures, cholestasis, liver parenchymal …

The microbiome landscape in pediatric Crohn's disease and therapeutic implications

K Fetter, M Weigel, B Ott, M Fritzenwanker… - Gut …, 2023 - Taylor & Francis
Dysbiosis of the gut microbiome and a pathological immune response in intestinal tissues
form the basis of Crohn's disease (CD), which is a debilitating disease with relevant …

Primary sclerosing cholangitis: review for radiologists

MA Morgan, R Khot, KM Sundaram, DR Ludwig… - Abdominal …, 2023 - Springer
Primary sclerosing cholangitis is a rare chronic inflammatory disease affecting the bile ducts,
which can eventually result in bile duct strictures, cholestasis and cirrhosis. Patients are …

Diagnosis of functional strictures in patients with primary sclerosing cholangitis using hepatobiliary contrast-enhanced MRI: a proof-of-concept study

S Poetter-Lang, A Messner, N Bastati, KI Ringe… - European …, 2023 - Springer
Objectives PSC strictures are routinely diagnosed on T2-MRCP as dominant-(DS) or high-
grade stricture (HGS). However, high inter-observer variability limits their utility. We …

Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis vs. viral hepatitis assessed by MR elastography

R Reiter, M Shahryari, H Tzschätzsch, D Klatt… - Scientific reports, 2021 - nature.com
Spatial heterogeneity of hepatic fibrosis in primary sclerosing cholangitis (PSC) in
comparison to viral hepatitis was assessed as a potential new biomarker using MR …

Quantitative spleen and liver volume changes predict survival of patients with primary sclerosing cholangitis

P Khoshpouri, B Hazhirkarzar, S Ameli, A Pandey… - Clinical Radiology, 2019 - Elsevier
AIM To assess the value of quantitative spleen and liver volume changes in predicting the
survival of patients with primary sclerosing cholangitis (PSC). MATERIALS AND METHODS …

Comparison of liver stiffness measurement with MRE and liver and spleen volumetry for prediction of disease severity and hepatic decompensation in patients with …

IS Idilman, HM Low, Z Bakhshi, J Eaton… - Abdominal …, 2020 - Springer
Purpose To compare liver stiffness measurement (LSM) with magnetic resonance
elastography (MRE) and liver and spleen volumetry for prediction of disease severity and …

The impact of hepatic and splenic volumetric assessment in imaging for chronic liver disease: a narrative review

N Kutaiba, W Chung, M Goodwin, A Testro, G Egan… - Insights into …, 2024 - Springer
Chronic liver disease is responsible for significant morbidity and mortality worldwide.
Abdominal computed tomography (CT) and magnetic resonance imaging (MRI) can fully …

Disease severity prognostication in primary sclerosing cholangitis: a validation of the Anali scores and comparison with the potential functional stricture

S Poetter-Lang, A Ba-Ssalamah, A Messner… - European …, 2024 - Springer
Objectives Our aim was twofold. First, to validate Anali scores with and without gadolinium
(ANALIGd and ANALINoGd) in primary sclerosing cholangitis (PSC) patients. Second, to …